GRAIL, Inc. (GRAL) vs RadNet, Inc. (RDNT)

GRAIL, Inc. and RadNet, Inc. are both Diagnostics & Research companies. GRAIL, Inc. and RadNet, Inc. are of similar size ($5.6B and $5.5B). GRAIL, Inc. grew revenue faster over the last twelve months: 23.1% against 18.9%. RadNet, Inc. has the higher net margin (−0.93% vs −237.0%) and the higher return on invested capital (2.24% vs −20.8%). Across the 17 metrics below, RadNet, Inc. leads on 12 and GRAIL, Inc. on 5.

Valuation

Metric GRAL RDNT Diagnostics & Research median
P/E n/m n/m 33.95
P/S 33.10 2.43 4.87
P/B 2.15 3.95 3.12
Price to free cash flow n/m 170.43 34.02
EV/EBITDA n/m 19.86 25.20
EV/Sales 27.89 2.69 5.66
Earnings yield (7.68%) (0.38%) (1.75%)
Free cash flow yield (5.41%) 0.59% (0.13%)

Profitability

Metric GRAL RDNT Diagnostics & Research median
Gross margin (31.31%) 11.53% 50.89%
Operating margin (338.40%) 3.12% (8.57%)
Net margin (236.95%) (0.93%) (6.37%)
Free cash flow margin (179.21%) 3.28% 0.00%
Return on equity (16.12%) (1.64%) (2.92%)
Return on assets (14.12%) (0.55%) (6.71%)
Return on invested capital (20.79%) 2.24% 0.00%

Growth

Metric GRAL RDNT Diagnostics & Research median
Revenue growth (TTM) 23.07% 18.92% 7.69%
EPS growth (last fiscal year) 82.51% (725.00%) —
Revenue growth, 5-year CAGR — 13.74% 7.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric GRAL RDNT Diagnostics & Research median
Debt to equity 0.00 0.94 0.11
Current ratio 10.95 1.48 2.02
Net debt to EBITDA 2.27 1.16 0.78

Dividend

Metric GRAL RDNT Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio — 0.00 0.00

Size

Metric GRAL RDNT Diagnostics & Research median
Market cap 5.54b 5.60b 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack